Winslow Evans & Crocker’s Calumet Specialty Products CLMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-2,000
Closed -$7.6K 1274
2017
Q1
$7.6K Hold
2,000
﹤0.01% 947
2016
Q4
$8K Sell
2,000
-206
-9% -$840 ﹤0.01% 932
2016
Q3
$9.95K Hold
2,206
﹤0.01% 909
2016
Q2
$10.8K Sell
2,206
-7,425
-77% -$42.1K ﹤0.01% 857
2016
Q1
$113K Sell
9,631
-1,025
-10% -$14.3K 0.03% 345
2015
Q4
$212K Sell
10,656
-10,712
-50% -$265K 0.06% 284
2015
Q3
$519K Sell
21,368
-494
-2% -$12.8K 0.16% 137
2015
Q2
$557K Sell
21,862
-1,556
-7% -$41.2K 0.16% 150
2015
Q1
$563K Buy
23,418
+12,360
+112% +$313K 0.16% 144
2014
Q4
$248K Buy
11,058
+458
+4% +$11.9K 0.07% 258
2014
Q3
$291K Buy
+10,600
New +$320K 0.08% 247

Other funds holding CLMT

Winslow Evans & Crocker's CLMT Position: Q2 2017 in Review

Winslow Evans & Crocker sold out of Calumet Specialty Products (CLMT) in Q2 2017, closing a stake of 2,000 shares — an estimated $7.6K sold.

Winslow Evans & Crocker first reported a position in CLMT in Q3 2014 and held it in 11 quarters. The position peaked at $563K in Q1 2015. 72 funds tracked by Wall St. Rank hold CLMT as of Q2 2017.

  • Winslow Evans & Crocker reported no remaining Calumet Specialty Products position as of Q2 2017 after selling out during the quarter.
  • Winslow Evans & Crocker sold 2,000 Calumet Specialty Products shares in Q2 2017, an estimated $7.6K.
  • Winslow Evans & Crocker first reported a position in Calumet Specialty Products in Q3 2014 and held it in 11 quarters.
  • Winslow Evans & Crocker's Calumet Specialty Products position peaked at $563K in Q1 2015.
  • 72 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q2 2017.

Based on Winslow Evans & Crocker's 13F filing for Q2 2017, filed 14 Jul 2017.